UC Asset LP: directors' dealings · United States · SEC (Form 4)

About UC Asset LP

UC Asset LP is a U.S.-based publicly traded company currently quoted on the OTCQB under the ticker UCASU, not on NYSE or NASDAQ based on the publicly available information reviewed. For French, Belgian, and Swiss investors, the company should be viewed as a niche real estate and thematic asset-investment vehicle with a specific focus on properties outfitted for specialized plant cultivation, especially medical cannabis. UC Asset LP describes itself as a master limited partnership (MLP) that invests in real estate assets equipped with advanced technologies designed for controlled cultivation environments. The company was formed on February 1, 2016, as a Delaware limited partnership in the United States, and it is managed by its general partner, UCF Asset LLC. Its headquarters are in Atlanta, Georgia, with an additional regional office in Edmond, Oklahoma. From a business-model perspective, UC Asset LP’s core activity is not direct cannabis production. Instead, it focuses on capital investment in limited liability companies and real estate, with an emphasis on growth-equity opportunities and income-oriented property exposure. That distinction matters: the company is essentially trying to monetize specialized real estate infrastructure rather than operate a cultivation business itself. This gives investors indirect exposure to the medical cannabis ecosystem while reducing some of the operational complexity associated with running agricultural production assets. According to its corporate materials, UC Asset LP positions itself as one of only a handful of publicly traded U.S. companies dedicated to cannabis property investment. That niche positioning can be attractive from a thematic standpoint, but it also implies a smaller scale, higher concentration risk, and sensitivity to financing conditions and regulatory developments. The company’s public market history shows that it began trading in 2019 and moved to OTCQB on January 2, 2024. On its investor relations page, UC Asset also references a planned secondary public offering of preferred shares of up to $10 million, with an 8% preferred dividend, which suggests a funding strategy that may rely on preferred capital rather than only common equity. Recent company materials include a 2025 white paper on cannabis property investment, reinforcing the firm’s strategic focus. For investors, the key analytical points remain the same: follow SEC filings closely, especially insider transaction Form 4 reports, monitor capital-raising activity, and keep in mind that communications from small-cap OTC issuers can be optimistic and should be verified against regulatory disclosures.